US 11040027
Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
granted A61KA61K31/437A61K31/501
Quick answer
US patent 11040027 (Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death) held by HEPAREGENIX GMBH expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- HEPAREGENIX GMBH
- Grant date
- Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/437, A61K31/501, A61P, A61P1/16